Difference between revisions of "Template:CombiCaLa"
From Psychiatrienet
(Created page with '* Abrupt stop of carbamazepine can cause serious lamotrigine rash as lamotrigine levels increase. <ref name="Koch"> {{Pubmed|12648898|Koch HJ et al. Clinically relevant reduction...') |
|||
| Line 1: | Line 1: | ||
| − | * Abrupt stop of carbamazepine can cause serious lamotrigine rash as lamotrigine levels increase. <ref name="Koch"> {{Pubmed|12648898|Koch HJ et al. Clinically relevant reduction of lamotrigine concentrations by carbamazepine. J Clin Psychiatry 2005;66:400-1}}</ref> | + | {{* Abrupt stop of carbamazepine can cause serious lamotrigine rash as lamotrigine levels increase. <ref name="Koch"> {{Pubmed|12648898|Koch HJ et al. Clinically relevant reduction of lamotrigine concentrations by carbamazepine. J Clin Psychiatry 2005;66:400-1}}</ref> |
* Carbamazepine likely speeds the metabolism of lamotrigine, but the clinical significance is unclear.<ref name="freeman"/><ref name="levyrh"> Levy RH et al, Metabolic Drug Interactions, Lippincott Williams & Wilkins, Philadelphia, 2000.</ref> | * Carbamazepine likely speeds the metabolism of lamotrigine, but the clinical significance is unclear.<ref name="freeman"/><ref name="levyrh"> Levy RH et al, Metabolic Drug Interactions, Lippincott Williams & Wilkins, Philadelphia, 2000.</ref> | ||
| Line 6: | Line 6: | ||
* These two agents have less significant pharmacologic interactions than do lamotrigine and valproate <ref name="freeman"/> | * These two agents have less significant pharmacologic interactions than do lamotrigine and valproate <ref name="freeman"/> | ||
| + | }} | ||
Revision as of 15:27, 22 April 2010
{{* Abrupt stop of carbamazepine can cause serious lamotrigine rash as lamotrigine levels increase. [1]
- Carbamazepine likely speeds the metabolism of lamotrigine, but the clinical significance is unclear.[2][3]
- Lamotrigine may increase blood levels of carbamazepine metabolites, which can result in neurotoxicity (data about this are contradictory). [2][3]
- These two agents have less significant pharmacologic interactions than do lamotrigine and valproate [2]
}}
- ↑ Koch HJ et al. Clinically relevant reduction of lamotrigine concentrations by carbamazepine. J Clin Psychiatry 2005;66:400-1
- ↑ 2.0 2.1 2.2 Cite error: Invalid
<ref>tag; no text was provided for refs namedfreeman - ↑ 3.0 3.1 Levy RH et al, Metabolic Drug Interactions, Lippincott Williams & Wilkins, Philadelphia, 2000.
